Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Henrich

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Biophysical Reports|October 27, 2022
Heterogeneous migration routes of DNA triplet repeat slip-outsSimona Bianco, Tianyu Hu, Oliver Henrich, et al.
The European Physical Journal. E, Soft Matter|May 12, 2018
Coarse-grained simulation of DNA using LAMMPS : An implementation of the oxDNA model and its applicationsOliver Henrich, Yair Augusto Gutiérrez Fosado, Tine Curk, et al.
Cancer Letters|August 30, 2008
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cellsChristian Praml, Wolfgang Schulz, Andreas Claas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
Nature Genetics|March 27, 2023
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcomeVerena Körber, Sabine A Stainczyk, Roma Kurilov, et al.
Cancer Letters|June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastomaIsabella Eckerle, Daniel Muth, Julia Batzler, et al.
British Journal of Cancer|September 29, 2022
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastomaH Lalchungnunga, Wen Hao, John M Maris, et al.
Cancer Research|March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cellsKai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Oncoimmunology|September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cellsSonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Biophysical Reports|October 27, 2022
Heterogeneous migration routes of DNA triplet repeat slip-outsSimona Bianco, Tianyu Hu, Oliver Henrich, et al.
The European Physical Journal. E, Soft Matter|May 12, 2018
Coarse-grained simulation of DNA using LAMMPS : An implementation of the oxDNA model and its applicationsOliver Henrich, Yair Augusto Gutiérrez Fosado, Tine Curk, et al.
Cancer Letters|August 30, 2008
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cellsChristian Praml, Wolfgang Schulz, Andreas Claas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
Nature Genetics|March 27, 2023
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcomeVerena Körber, Sabine A Stainczyk, Roma Kurilov, et al.
Cancer Letters|June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastomaIsabella Eckerle, Daniel Muth, Julia Batzler, et al.
British Journal of Cancer|September 29, 2022
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastomaH Lalchungnunga, Wen Hao, John M Maris, et al.
Cancer Research|March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cellsKai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Oncoimmunology|September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cellsSonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Pageof 5